Event Schedule

MONDAY MARCH 30, 2019
SESSION 1 - ANTIBODY-BASED DRUG DEVELOPMENT
SESSION 2 - NANOMEDICINE AGAINST INFECTIOUS DISEASES;
SESSION 3 - IMMUNOTHERAPY AGAINST EMERGING INFECTIOUS DISEASES

TUESDAY MARCH 31, 2019
SESSION 4 - IMMUNOTHERAPY AGAINST VIRAL INFECTIONS;
SESSION 5 - IMMUNOTHERAPY AGAINST BACTERIAL INFECTIONS;

WEDNESDAY APRIL 1, 2019
SESSION 6 - PRODUCTION AND REGULATORY CHALLENGES;
SESSION 7 - 3RS PRINCIPLES IN BIOTECHNOLOGICAL AND MEDICAL APPLICATIONS
CONCLUSIONS AND REMARKS

MONDAY March 30, 2020

Speakers and sessions

SESSION 1 - ANTIBODY-BASED DRUG DEVELOPMENT

Keynote Speaker: Davide Corti, IRB, Switzerland
Andreas Laustsen, Technical University of Denmark, Denmark - Speaker from VIRMAB
Anna Codina, Bruker Biospin - from BRUKER
Selected abstracts for oral presentations
Poster Session

Speakers and sessions

SESSION 2 - NANOMEDICINE AGAINST INFECTIOUS DISEASES

Donata Medaglini, University of Siena, Italy
Jennifer Grossman, National Institute of Health, USA

Speakers and sessions

SESSION 3 - IMMUNOTHERAPY AGAINST EMERGING INFECTIOUS DISEASES

Keynote Speaker: Antonio Lanzavecchia, IRB, Switzerland
Lisa Purcell from REGENERON
Luca Varani, IRB, Switzerland
Keynote Speaker: Man-Wah Tan, Genentech, USA

TUESDAY March 31, 2020

Speakers and sessions

SESSION 4 - IMMUNOTHERAPY AGAINST VIRAL INFECTIONS

Keynote Speaker: Hugo Mouquet, Institut Pasteur, France
Pongrama Ramasoota, Mahidol University, Bangkok, Thailand
Nancy Haigwood, Oregon National Primate Research Center, Oregon Health and Science University, USA
Fausto Baldanti, Policlinico San Matteo, IRCCS, Pavia, Italy
Selected abstracts for oral presentations
Poster Session

Speakers and sessions

SESSION 5 - IMMUNOTHERAPY AGAINST BACTERIAL INFECTIONS

Keynote Speaker: Larry Zeitlin, Mapp Biopharmaceutical, USA
Bernhard B. Singer, University Hospital Essen, Germany
Theam Soon Lim, University SainsMalaysia (USM), Penang, Malaysia
Michael Hust, Technische Universität Braunschweig, Germany
Selected abstracts for oral presentations

WEDNESDAY April 1, 2020

Speakers and sessions

SESSION 6 - PRODUCTION AND REGULATORY CHALLENGES

Sumathi Nambiar, U.S. Food and Drug and Administration
Leander Grode, VPM GmbH, Hannover, Germany
Marisa Papaluca, former senior scientist, European Medicinal Agency

Speakers and sessions

SESSION 7 - 3RS PRINCIPLES IN BIOTECHNOLOGICAL AND MEDICAL APPLICATIONS

Laura Gribaldo, Scientific Officer, European Commission Joint Research Centre
Jeff Brown, PETA International Science Institute, USA (3R and Infectious Disease)
Ida Retter, Charité, Berlin, Germany

12:00-12:15 CONCLUSIONS AND REMARKS

Sponsors

This event is possible thanks to the contribution of

Platinum Sponsor
Preclinics
Platinum Sponsor
Vir Biotechnology
Gold Sponsor
YUMAB
Silver Sponsor
HOEPLI
Public

Young scientists & Academics

  • Includes all meals!
  • Comfortable Seat
  • Coffee Break
  • Poster session
  • Certificate
  • Registration will NOT includes the cost of accommodation
Buy Ticket
Private

Private

  • Includes all meals!
  • Comfortable Seat
  • Coffee Break
  • Poster session
  • Certificate
  • Registration will NOT includes the cost of accommodation
Buy Ticket